PRESS RELEASE
Las Vegas, Nevada – November 20, 2026 – Cannvital NV LLC (“Cannvital”), a U.S.-based manufacturer of high-purity hemp-derived cannabinoids, proudly announces that it has successfully completed an independent audit and received 21 CFR Parts 210/211 Current Good Manufacturing Practice (cGMP) certification from Perry Johnson Registrars (PJR), a recognized third-party certification organization.
The certification scope covers the “Manufacture of Pharmaceutical Grade CBD and Other Cannabinoid Ingredients,” marking a significant milestone in Cannvital’s expansion into the pharmaceutical ingredient market.
Building upon its existing 21 CFR Part 117 food-grade cGMP certification, this achievement demonstrates Cannvital’s continued investment in pharmaceutical quality systems, manufacturing controls, material traceability, equipment qualification, process validation, and comprehensive documentation.
The U.S. FDA’s 21 CFR Parts 210/211 and the internationally recognized ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (APIs) share fundamental principles of quality management, process control, validation, documentation, and product consistency. Although the two frameworks are not identical, their substantial overlap provides a strong foundation for Cannvital’s continued alignment with international API manufacturing expectations.
“This achievement represents an important step in our commitment to supplying high-quality cannabinoid ingredients to the global pharmaceutical industry,” said a Cannvital spokesperson. “It reinforces our dedication to regulatory compliance, consistent product quality, and meeting the increasingly stringent requirements of pharmaceutical customers worldwide.”
Operating from its 22,000-square-foot manufacturing facility in Las Vegas, Cannvital is positioned to support pharmaceutical manufacturers, formulation developers, and international partners seeking reliable, high-purity cannabinoid ingredients.
The certification further strengthens Cannvital’s strategic expansion into regulated pharmaceutical markets, including the United States, Europe, Japan, and other international markets.
About Cannvital NV LLC
Cannvital NV LLC is a U.S.-based manufacturer specializing in high-purity hemp-derived CBD and other cannabinoid ingredients. The company focuses on advanced manufacturing, rigorous quality assurance, and reliable supply solutions for pharmaceutical and other regulated applications.